amrinone has been researched along with Substance Withdrawal Syndrome in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighteen patients with congestive heart failure were studied in a double-blind, randomized, placebo-controlled withdrawal trial to evaluate the effectiveness of chronic oral amrinone therapy when added to conventional heart failure therapy." | 9.05 | Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study. ( Bashore, TM; Evans, JR; Huss, P; Leier, CV; Pacht, K; Unverferth, DV, 1984) |
| "Eighteen patients with congestive heart failure were studied in a double-blind, randomized, placebo-controlled withdrawal trial to evaluate the effectiveness of chronic oral amrinone therapy when added to conventional heart failure therapy." | 5.05 | Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study. ( Bashore, TM; Evans, JR; Huss, P; Leier, CV; Pacht, K; Unverferth, DV, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, JR | 1 |
| Pacht, K | 1 |
| Huss, P | 1 |
| Unverferth, DV | 1 |
| Bashore, TM | 1 |
| Leier, CV | 1 |
1 trial available for amrinone and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study.
Topics: Administration, Oral; Adult; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Clinical Trials as | 1984 |